Sustained effect of high-dose intrathecal baclofen in primary generalized dystonia: a 2-year follow-up study.
Diederich
N J
NJ
Department of Neurosciences, Centre Hospitalier de Luxembourg.
Comella
C L
CL
Matge
G
G
Becker
G
G
Schiltz
F
F
Metz
H
H
D000328:Adult; D001418:Baclofen / Q000627:therapeutic use*; D019274:Botulinum Toxins, Type A / Q000627:therapeutic use; D002408:Catheters, Indwelling; D004305:Dose-Response Relationship, Drug; D004359:Drug Therapy, Combination; D004421:Dystonia / Q000188:drug therapy*; D005500:Follow-Up Studies; D006801:Humans; D015918:Infusion Pumps, Implantable; D008137:Longitudinal Studies; D008297:Male; D009125:Muscle Relaxants, Central / Q000627:therapeutic use*
D009125:Muscle Relaxants, Central; D019274:Botulinum Toxins, Type A; D001418:Baclofen